“A STUDY OF OCT3/4 EXPRESSION IN HER2/NEU POSITIVE BREAST CANCER PATIENTS”, IABCD, vol. 1, no. 2, pp. 342–348, Dec. 2022, doi: 10.56588/iabcd.v1i2.93.